Global Cardiovascular & Soft Tissue Repair Patches Market by Raw Material (Biomaterial, ePTFE), by Application (Cardiac, Soft Tissue) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global soft tissue and cardiovascular repair patches markets were valued at USD 3.28 Billion in 2018. They are expected to grow at an 8.2% compound annual growth rate (CAGR), from 2019 to 2025. The key drivers are technological advances and the increasing prevalence of congenital heart disease such as atrial septal defect, ventricular septal defect, and ventricular septal defects. Technological advances have a multidimensional impact on product development, product design and raw material fabrication as well as clinical evaluation.

These patches can be used for tissue repair procedures, including soft tissue, dural, vascular repairs and reconstructions. Market growth will be positively affected by the increasing prevalence of hernias like congenital diaphragmatic and inguinal hernias. Inguinal hernia repair is one of the most common general surgeries. According to the International Surgery Journal research article, the U.S. rate for inguinal hernia repairs was 28 per 100,000.

The market will also benefit from increased collaboration between raw material suppliers, research organizations, and manufacturers. The market will also be boosted by the development of new technologies that use tissue engineering materials. Researchers at Tel Aviv University of Israel have created a bionic heart patch, which could help patients recover from heart attacks.

The market for cardiovascular and soft tissue patches will also benefit from government initiatives to increase access to cardiac treatments. The Osaka Medical College collaborated with Teijin Limited, Fukui Warp Knitting Co. Ltd. to develop a long-lasting regenerative cardiac repair patches. The Japanese government supported this project, which aims to encourage collaborations between medical and industrial fields.

Application Insights

Soft tissue repair segment held 42.4% of the market in 2018, which was a result of increasing prevalence of different types of hernias like umbilical hernias and ventral hernias.

The fastest-growing application area is cardiac repair, which is projected to grow at 8.8% CAGR over the forecast period. The demand for pediatric cardiac surgery is expected to grow in the coming seven years, as congenital heart disease is a common condition in children.

Raw Material Insights

Tissue engineered material, ePTFE and are the main raw material segments. Biomaterial and ePTFE are the main raw materials for manufacturing soft and cardiovascular tissue. In 2018, ePTFE accounted for 62.6% of the overall market. This growth can be attributed to the easy availability of raw material, high strength and durability, and other key factors.

Biomaterial and tissue-engineered materials are growing in popularity. This segment will see the fastest CAGR at 9.4% over the forecast period. The most commonly used raw material is bovine pericardium. It is more widely accepted due to its chemical and physical properties. There are many benefits associated with it, including the acceptance in the human body and potential complications after surgery.

High amounts of structural protein in bovine patches provide good flexibility and conformity, depending on the anatomical circumstances. These patches can easily be tailored to fit different sizes and configurations. To reduce the risk of calcification, bovine patches are usually treated with proprietary solutions. Edwards Lifesciences uses the XenoLogiX technology and St. Jude Medical uses EnCap AC Technology. These patches are more reliable, convenient, and improve biocompatibility.

Regional Insights

In 2018, North America accounted for the largest revenue share. The key factors that are driving regional growth positively include the increasing prevalence of heart disease due to obesity, smoking, drinking, and other drug abuse. The availability of new products and a well-developed healthcare infrastructure will likely increase the use of heart and soft tissue repair patches.

Asia Pacific will likely experience the fastest CAGR during the forecast period. Market forces include improved healthcare systems that diagnose and manage heart disease, especially in low- and middle-income countries. Asia Pacific has 60% of the world's population, and the majority are over 60 years old. This is a major reason for the rapid rise in non-communicable disease (mainly cardiovascular) in this region.

China is one of Asia Pacific's most important markets. The availability of various treatments such as the implantation of a cardiac patch has increased due to rising concerns about congenital heart disease prevention and early detection. The World Health Organization (WHO) data shows that annual cardiovascular events will increase by 50% between 2010- 2030. This is a huge market opportunity.

Market Share Insights & Key Companies

The market's current competition is evident by the increasing number of mergers and acquisitions of key players such as Terumo Cardiovascular or Medtronic. The market for soft tissue repair patches and cardiovascular medicine is dominated by the following players:

• Medtronic

• Bard Peripheral Vascular, Inc.

• Terumo Cardiovascular

• W.L. Gore & Associates

• GETINGE Group

• CryoLife

• Edwards Life Sciences

• Baxter

• Admedus

Up Market Research published a new report titled “Cardiovascular & Soft Tissue Repair Patches Market research report which is segmented by Raw Material (Biomaterial, ePTFE), by Application (Cardiac, Soft Tissue), By Players/Companies Edwards Life Sciences, Medtronic, GETINGE Group, WL Gore & Associates, Admedus, Bard Peripheral Vascular Inc, Baxter, Terumo Cardiovascular, CryoLife”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Cardiovascular & Soft Tissue Repair Patches Market Report Segments:

The market is segmented by Raw Material (Biomaterial, ePTFE), by Application (Cardiac, Soft Tissue).

Cardiovascular & Soft Tissue Repair Patches Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Cardiovascular & Soft Tissue Repair Patches Market

Overview of the regional outlook of the Cardiovascular & Soft Tissue Repair Patches Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Cardiovascular & Soft Tissue Repair Patches Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Cardiovascular & Soft Tissue Repair Patches Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Biomaterial

                2. ePTFE

                1. Cardiac

                2. Soft Tissue

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cardiovascular & Soft Tissue Repair Patches Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Cardiovascular & Soft Tissue Repair Patches Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.